Table 3.
Variable | Capecitabine (n = 48) | 5-FU (n = 109) | Odds ratioa | 95 % confidence interval | |
---|---|---|---|---|---|
Gender | |||||
Female | 21 (35%) | 39 (65%) | Ref. | – | – |
Male | 27 (28%) | 70 (72%) | 1.10 | 0.45 | 2.69 |
Age | |||||
Age at treatment commencement (per year) | 66.95 | 62.55 | 1.02 | 0.98 | 1.07 |
Marital status | |||||
Married | 20 (26%) | 57 (74%) | Ref. | – | – |
Widowed, divorced/separated, never married | 19 (32%) | 40 (68%) | 1.67 | 0.62 | 4.45 |
Religious affiliation | |||||
Religious | 23 (28%) | 59 (72%) | Ref. | – | – |
Not religious | 5 (19%) | 21 (81%) | 0.42 | 0.10 | 1.77 |
Distance required to travel to hospital (km) | |||||
0–5 | 25 (33%) | 50 (67%) | Ref. | – | – |
5–10 | 15 (30%) | 35 (70%) | 0.74 | 0.27 | 2.02 |
10–40 | 6 (32%) | 13 (68%) | 1.47 | 0.39 | 5.47 |
>40 | 2 (15%) | 11 (85%) | 0.22 | 0.05 | 0.94 |
Treatment delay | |||||
Time from diagnosis to treatment (per month) | 10.04 | 7.18 | 1.02 | 1.00 | 1.04 |
Treatment decision | |||||
Physician | 7 (15%) | 39 (85%) | Ref. | – | – |
One option discussed | 6 (16%) | 31 (84%) | 1.41 | 0.38 | 5.20 |
Physician recommended | 4 (22%) | 14 (78%) | 1.41 | 0.29 | 6.86 |
Patient | 27 (68%) | 13 (33%) | 17.51 | 5.37 | 57.08 |
Ambiguous | 4 (25%) | 12 (75%) | 2.40 | 0.47 | 12.31 |
aOdds ratios adjusted for all variables in the logistic regression